Mills, Jr, et al. “Bacterial Resistance and Therapeutic Outcome Following Three Months of Topical Acne Therapy With 2% Erythromycin Gel Versus Its Vehicle”. Acta Dermato-Venereologica, vol. 82, no. 4, Oct. 2002, pp. 260-5, doi:10.1080/000155502320323216.